Maternal Health and Neonatal Health Solutions

Global women's health solutions company

Delivering Innovations to your teams. Anywhere.

Browse Solutions COVID-19

Maternova licenses innovative femtech & medtech from startups.

We then make it easy for distributors, governments and humanitarian organizations to research, source and fulfill orders of trusted medical devices and diagnostics.

COVID-19 IgG/IgM Antibody Test

Quick View

COVID-19 IgG/IgM Antibody Test

Non-Pneumatic Anti Shock Garment

Quick View

Non-Pneumatic Anti Shock Garment

Hepatitis B, Hepatitis C, HIV Test

Quick View

Hepatitis B, Hepatitis C, HIV Test

ThermoSpot Stick-On Reusable Newborn Thermoindicators

Quick View

ThermoSpot Stick-On Reusable Newborn Thermoindicators

HIV 1 / HIV 2 Rapid Test

Quick View

HIV 1 / HIV 2 Rapid Test

Pratt Pouch for ARV for HIV

Quick View

Pratt Pouch for ARV for HIV

HIV-1, HIV-2, Syphilis Antibody Test

Quick View

HIV-1, HIV-2, Syphilis Antibody Test

Chlamydia Rapid Test

Quick View

Chlamydia Rapid Test

Schistosomiasis Rapid Test

Quick View

Schistosomiasis Rapid Test

F-100 Therapeutic Milk

Quick View

F-100 Therapeutic Milk

CRADLE Vital Signs Monitor

Quick View

CRADLE Vital Signs Monitor

Infant Resuscitator - Infant Ambu Bag

Quick View

Infant Resuscitator - Infant Ambu Bag

Micronutrient powder (MNP)

Quick View

Micronutrient powder (MNP)

Uterine balloon tamponade (MOQ 10 balloons)

Quick View

Uterine balloon tamponade (MOQ 10 balloons)

Pregnancy Test (hCG)

Quick View

Pregnancy Test (hCG)

As seen in:

The Maternova blog

Anemia in Pregnancy: A Public Health Problem

June 18, 2022

Anemia and pregnancy: a public health problem Anemia is a condition characterized by a decrease in the concentration of red blood cells or hemoglobin below normal values. In pregnancy, due...

Can preeclampsia be prevented?

June 01, 2022

Can preeclampsia be prevented? Preeclampsia, defined as new onset of hypertension (≥140/90 mmHg), usually after 20 weeks of gestation associated with proteinuria, (1) complicates 2-3% of all pregnancies (2) and...

How I Survived Eclampsia through an Emergency Visit After a Birth in Borno State, Nigeria

January 15, 2022

Aisha Mohammed was an unbooked client-- she delivered at home in a remote village near Kidang town in Hawul LGA of Borno state Nigeria. Unbooked means that she had no...

In 2017 WHO added TXA to its Postpartum Hemorrhage Recommendations

December 28, 2021

The WOMAN Trial (World Maternal Antifibrinolytic Trial) was an international randomized double-blind, placebo controlled trial that began in 2010 to investigate the effect of early administration of tranexamic acid on morbidity, mortality,...